MISSION 2010MSRecalls & reported problems
Bard Peripheral Vascular, Inc. · Mission Disposable Core Biopsy Instrument - 20Gx10cm · Class 2
All models of MISSION (20)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00801741097027), received between Nov 9, 2020 and Aug 7, 2023 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Device Contamination with Chemical or Other Material” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Device Contamination with Chemical or Other Material1
- Device Markings/Labelling Problem1
- Difficult to Remove1
- Failure to Fire1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Hematoma1
- Hemoptysis1
- Hemorrhage/Blood Loss/Bleeding1
- Pain1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 7, 2023Difficult to Remove; Failure to Fire; Device Contamination with Chemical or Other Material; Difficult to Remove; Failure to Fire; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT DURING A BIOPSY PROCEDURE, THE RESISTANCE WAS ALLEGEDLY NOT SMOOTH WHEN THE NEEDLE WAS PULLED OUT. IT WAS FURTHER REPORTED THAT AFTER REMOVING THE NEEDLE, AN IRON WIRE WAS ALLEGEDLY FOUND INSIDE. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17468638 ↗MalfunctionMar 23, 2022Device Markings/Labelling Problem; Device Markings/Labelling Problem
IT WAS REPORTED THAT PRIOR TO A BIOPSY PROCEDURE, THE LABELS IN THE PRODUCT AND THE PACKAGE WERE ALLEGEDLY MISMATCHING. THERE WAS NO PATIENT CONTACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13860685 ↗InjuryNov 9, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH A (B)(6) CLINICAL FOLLOW-UP SURVEY ON CORE BIOPSY INSTRUMENTS, THERE WERE 2 OCCURRENCES OF HEMATOMA, 2 OCCURRENCES OF HEMORRHAGE, AND 2 OCCURRENCES OF PAIN DURING KIDNEY BIOPSY PROCEDURE(S). IT WAS FURTHER REPORTED THERE WAS 1 OCCURRENCE OF HEMOPTYSIS REQUIRING HOSPITALIZATION OR SPECIFIC THERAPY, 2 OCCURRENCES OF PAIN, AND 2 OCCURRENCES OF THORACOSTOMY TUBE PLACEMENT REQUIRING PROLONGED ADMISSION, CATHETER EXCHANGE OR PLEURODESIS DURING LUNG BIOPSY PROCEDURE(S). THERE CURRENT STATUS OF THE PATIENT(S) WAS NOT PROVIDED.
Patient problems: Hematoma; Hemoptysis; Hemorrhage/Blood Loss/Bleeding; Pain
MAUDE report 10808124 ↗
Other INSTRUMENT, BIOPSY devices
- MAX-CORE MC1616Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall4,258 reports
- ENCOR® ECP017GSenorx, Inc. · INSTRUMENT, BIOPSY1 recall4,186 reports
- MAX-CORE MC1820Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall2,404 reports
- MAX-CORE MC1816Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall1 death848 reports
- MAX-CORE MC1410Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall399 reports
- MAX-CORE MC1610Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall394 reports
- ENCOR® ECP0110GVSenorx, Inc. · INSTRUMENT, BIOPSY392 reports
- ENCOR® ECP0110GSenorx, Inc. · INSTRUMENT, BIOPSY390 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page